ARS Pharmaceuticals, Inc (SPRY : NASDAQ)
Common Stock
Follow SPRY
SPRY
ARS Pharmaceuticals, Inc
WealthAwesomePerformance
1 Day
+13.33%
1 Week
+17.05%
1 Month
-15.60%
YTD
-63.94%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$358.89M
52W High
$13.15
52W Low
$2.44
P/E Ratio
-
50 Day MA
$4.24
200 Day MA
$7.16
Beta
1.16
Dividend Yield
-
Performance history
SPRY returns since 2026
ARS Pharmaceuticals, Inc has traded since Jun 2026 in our data. Its deepest fall was −74.9% (Jun 2026 to Nov 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−63.9%
* Partial year (first year of data, or year to date).
$10,000 invested in SPRY
- 2026 (start of our data)$3,606
- All-time high in our data
- $11 on Jun 24, 2026 · now −66.1%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past SPRY? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $3.15 | $3.74 | $3.07 | $3.57 | $3.57 | 2,903,270 |
| 11/9/2026 | $2.80 | $3.17 | $2.73 | $3.15 | $3.15 | 3,185,266 |
| 11/6/2026 | $2.66 | $2.84 | $2.44 | $2.79 | $2.79 | 5,672,400 |
| 11/5/2026 | $3.05 | $3.10 | $2.59 | $2.65 | $2.65 | 2,767,815 |
| 11/4/2026 | $3.13 | $3.23 | $3.00 | $3.05 | $3.05 | 2,486,342 |
| 11/3/2026 | $3.05 | $3.11 | $2.92 | $3.05 | $3.05 | 2,422,127 |
| 11/2/2026 | $3.40 | $3.49 | $2.91 | $3.05 | $3.05 | 2,120,240 |
| 10/30/2026 | $3.62 | $3.79 | $3.34 | $3.38 | $3.38 | 1,754,300 |
| 10/29/2026 | $3.70 | $3.90 | $3.63 | $3.66 | $3.66 | 2,044,359 |
| 10/28/2026 | $3.69 | $3.73 | $3.52 | $3.65 | $3.65 | 2,532,675 |
Analyst Price Targets
Based on 4 analysts covering SPRY · as of Nov 10, 2026
Wall Street analysts forecast SPRY stock price to rise 376.2% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$17.00
+376.2% Upside
Previously US$20.33 on Nov 9, 2026
Current Price
US$3.57
Last close
Analyst Breakdown (4 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SPRY's historical volatility
30-Day Vol
92.3%
Annualized
90-Day Vol
78.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$2.99
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$3.36 | US$2.45 – US$4.62 |
| 60 trading days | US$3.17 | US$2.02 – US$4.97 |
| 90 trading days | US$2.99 | US$1.72 – US$5.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About ARS Pharmaceuticals, Inc
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Financials
- Revenue (TTM)
- $122.14M
- EBITDA
- $-195.60M
- Profit Margin
- -163.64%
- ROE (TTM)
- -294.57%
- EPS (Diluted)
- -2.01
- Book Value
- -0.12
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About SPRY.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| PEPG | PepGen Ltd | $4.61 | +92.89% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |
Free with a Wealth Awesome account
Keep analysing SPRY, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.